How Do Patients Value Features of Biological Medicine in Rheumatoid Arthritis? a Discrete Choice Experiment Publisher Pubmed



Zartab S¹ ; Nikfar S² ; Jamshidi A³ ; Toroski M² ; Varahrami V⁴ ; Fatemi B² ; Kebriaeezadeh A^{2, 5} Show Affiliations
Source: Expert Review of Pharmacoeconomics and Outcomes Research Published:2023

Abstract

Background: The aim of this study was to quantify the preference of the patients regarding biological DMARDs. Research design and methods: Patients’ preferences were assessed using a discrete choice experiment. Eighteen different surveys describing eight attributes were designed using experimental design methods. Each survey presented eight choice tasks with two options for patients to choose one. A conditional logit model was used to calculate relative importance and willingness to pay. Subgroup analysis was conducted to evaluate the effect of the patients’ characteristic on their preferences. Results: A total of 306 patients were included in the study. All attributes had significant effects on the patients’ choices. The most important feature was the ability to preserve physical function. The least important feature was the route of administration. Surprisingly, the out-of-pocket cost was one of the last priorities for respondents. According to the relative importance calculations, 80% of the patients’ preferences can be obtained by clinical attributes. Based on subgroup analysis, the most important patient characteristic that affected their choices was the monthly out-of-pocket history. Conclusions: Different features of treatment had different effects on the patients’ preferences. Quantification of the impact of each attribute not only revealed their relative importance but also determined the trade-off rate among them. © 2023 Informa UK Limited, trading as Taylor & Francis Group.